Reports and Briefs on Pharmaceuticals and Healthcare in Europe

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Report
Report

Women's Health Market Strategies - Opportunities remain in this overlooked therapy area

This report aims to explore the opportunities and challenges in the women’s health sector. Market access is evaluated and includes analysis of drug sales, key players, regulatory trends, licensing deals, unmet needs, and marketing strategies.

Published By Datamonitor
12 Oct 2011 $2800
Buy
Brief
Brief

Walgreens | Verdict Company Briefing

A one stop destination for the latest data and opinion on the US retailer. Aimed at retailers and stakeholders, we analyse Walgreens US business and assess the prospects of its investment in Alliance Boots.

Published By Verdict
12 Jul 2012 $400
Buy
Brief
Brief

UK Healthcare System Overview

NHS reform is impacting pharmaceutical companies’ interaction with key stakeholders.

Published By Datamonitor
25 Mar 2013 $400
Buy
Report
Report

Turkey: Pharmaceutical Industry Infrastructure Overview

This report provides an overview of research and development, manufacturing, outsourcing, and distribution trends, as well as infrastructure profiles for the leading pharmaceutical companies in Turkey.

Published By Datamonitor
29 Jun 2011 $1520
Buy
Report
Report

Turkey: Healthcare System and Drug Regulatory Overview

This report provides an overview of healthcare expenditure, the insurance and healthcare system, healthcare reforms, drug regulation and intellectual property, and drug pricing and reimbursement in Turkey.

Published By Datamonitor
01 Jul 2011 $1520
Buy
Report
Report

Turkey: Generics and Biosimilars Overview

Overview of the generics and biosimilars landscape including, regulatory issues, drivers and resistors to uptake, level of penetration, and key players operating in the market.

Published By Datamonitor
29 Jun 2011 $1520
Buy
Report
Report

Treatment Algorithms: Type 2 Diabetes – Novel classes drive fragmentation of treatment choices in type 2 diabetes

Datamonitor reports average patient population and prescribing behavior by therapy line in the seven major markets, as well as analysis of therapy switching, patient share by drug class, and class use trends, based on a 199-physician survey.

Published By Datamonitor
27 Jul 2011 $4800
Buy
Report
Report

Treatment Algorithms: Schizophrenia – New antipsychotic launches underwhelm

Analysis of current treatment dynamics in schizophrenia. The report assesses patient diagnosis rates and uptake rates of approved treatments across the seven major markets using Datamonitor’s primary physician research of 140 psychiatrists.

Published By Datamonitor
15 May 2012 $4800
Buy
Report
Report

Treatment Algorithms: Rectal Cancer – Inclusion of chemoradiation can influence treatment and prescribing trends

This report provides analysis of current treatment dynamics of rectal cancer. Based on Datamonitor’s survey of 127 oncologists and cancer treaters the report assesses treatment type, prescribing influences, and patient numbers across disease stages.

Published By Datamonitor
26 Apr 2012 $4800
Buy
Report
Report

Treatment Algorithms: Psoriasis – Prescribing trends mirror guidelines

In this report, Datamonitor provides detailed treatment paths based on a survey of 125 dermatologists across the seven major markets, with analysis of patient potential, patient segmentation, prescribing patterns, and compliance among these patients.

Published By Datamonitor
21 Feb 2012 $4800
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.